James Larkin
The Royal Melbourne Hospital(AU)Trinity College Dublin(IE)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma(2015)8,055 cited
- → Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing(2012)7,706 cited
- → Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation(2011)7,653 cited
- → Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma(2015)5,840 cited
- → Pembrolizumab versus Ipilimumab in Advanced Melanoma(2015)5,779 cited
- → Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2017)5,338 cited
- →